Monday, 31 March 2014

GSK CEO says success of heart drug 'an open question'

(Reuters) - The success or failure of GlaxoSmithKline's experimental heart drug darapladib remains "an open question" and will hinge on a second pivotal clinical study, the company's chief executive said on Monday.















via Reuters: Health News Read More Here..

No comments:

Post a Comment